PubMed

Controlling off-label medication use.

Gillick MR.

Ann Intern Med. 2009 Mar 3;150(5):344-7. Epub 2009 Feb 16.PMID: 19221367 [PubMed - indexed for MEDLINE]Related articlesFree article

Evaluating off-label uses of anticancer drugs: time for a change.

Sox HC.

Ann Intern Med. 2009 Mar 3;150(5):353-4. Epub 2009 Feb 16. No abstract available. PMID: 19221369 [PubMed - indexed for MEDLINE]Related articlesFree article

Compendia and anticancer therapy under Medicare.

Tillman K, Burton B, Jacques LB, Phurrough SE.

Ann Intern Med. 2009 Mar 3;150(5):348-50. Epub 2009 Feb 16.PMID: 19221368 [PubMed - indexed for MEDLINE]Related articlesFree article

Systematic review: reliability of compendia methods for off-label oncology indications.

Abernethy AP, Raman G, Balk EM, Hammond JM, Orlando LA, Wheeler JL, Lau J, McCrory DC.

Ann Intern Med. 2009 Mar 3;150(5):336-43. Epub 2009 Feb 16. Review. Erratum in: Ann Intern Med. 2009 Apr 21;150(8):571. PMID: 19221366 [PubMed - indexed for MEDLINE]Related articlesFree article

Off-label cancer drug compendia found outdated and incomplete.

Mitka M.

JAMA. 2009 Apr 22;301(16):1645-6. No abstract available. PMID: 19383947 [PubMed - indexed for MEDLINE]Related articles

Coverage policy and use beyond the FDA-approved label.

McGivney WT.

J Natl Compr Canc Netw. 2006 Feb;4(2):99-101. No abstract available. PMID: 16451768 [PubMed - indexed for MEDLINE]Related articles

Medicare challenges and solutions--reimbursement issues in treating the patient with colorectal cancer.

Kaa K.

J Manag Care Pharm. 2007 Aug;13(6 Suppl C):S19-26.PMID: 17713991 [PubMed - indexed for MEDLINE]Related articlesFree article

Contradictory actions on off-label use of prescription drugs? The FDA and CMS versus the U.S. Justice Department.

Curtiss FR, Fairman KF.

J Manag Care Pharm. 2009 Mar;15(2):161-5. No abstract available. PMID: 19236131 [PubMed - indexed for MEDLINE]Related articlesFree article

Reimbursement for cancer treatment: coverage of off-label drug indications.

American Society of Clinical Oncology.

J Clin Oncol. 2006 Jul 1;24(19):3206-8. Epub 2006 May 22.PMID: 16717290 [PubMed - indexed for MEDLINE]Related articles

Off-label prescribing among office-based physicians.

Radley DC, Finkelstein SN, Stafford RS.

Arch Intern Med. 2006 May 8;166(9):1021-6.PMID: 16682577 [PubMed - indexed for MEDLINE]Related articlesFree article

Off-label prescribing: a call for heightened professional and government oversight.

Dresser R, Frader J.

J Law Med Ethics. 2009 Fall;37(3):476-86, 396.PMID: 19723258 [PubMed - indexed for MEDLINE]Related articles

The use of Food and Drug Administration--approved medications for unlabeled (off-label) uses. The legal and ethical implications.

Torres A.

Arch Dermatol. 1994 Jan;130(1):32-6.PMID: 8285737 [PubMed - indexed for MEDLINE]Related articles

Prescribing medications in pediatrics: concerns regarding FDA approval and pharmacokinetics.

Novak E, Allen PJ.

Pediatr Nurs. 2007 Jan-Feb;33(1):64-70. Review.PMID: 17411005 [PubMed - indexed for MEDLINE]Related articles

Unapproved uses of approved drugs: the physician, the package insert, and the Food and Drug Administration: subject review. American Academy of Pediatrics Committee on Drugs.

[No authors listed]

Pediatrics. 1996 Jul;98(1):143-5. Review.PMID: 8668390 [PubMed - indexed for MEDLINE]Related articles

Prioritizing future research on off-label prescribing: results of a quantitative evaluation.

Walton SM, Schumock GT, Lee KV, Alexander GC, Meltzer D, Stafford RS.

Pharmacotherapy. 2008 Dec;28(12):1443-52.PMID: 19025425 [PubMed - indexed for MEDLINE]Related articles

FDA proposes new rules for off-label use of prescription drugs. Food and Drug Administration.

Baker R.

BETA. 1998 Jul:8-9.PMID: 11365570 [PubMed - indexed for MEDLINE]Related articles

Antineoplastic agents: comparing off-label uses among authoritative drug compendia.

Thompson DF, Keefe CC.

Hosp Formul. 1993 Jul;28(7):641-2, 647.PMID: 10127046 [PubMed - indexed for MEDLINE]Related articles

Effect of off-label use of oncology drugs on pharmaceutical costs: the rituximab experience.

Kocs D, Fendrick AM.

Am J Manag Care. 2003 May;9(5):393-400; quiz 401-2.PMID: 12744301 [PubMed - indexed for MEDLINE]Related articlesFree article

Using the MADIT II criteria for implantable cardioverter defibrillators-what is the role of the Food and Drug Administration approval?

Barold HS.

Card Electrophysiol Rev. 2003 Dec;7(4):443-6.PMID: 15071272 [PubMed - indexed for MEDLINE]Related articles

Medicare Part D: selected issues for pharmacists and beneficiaries in 2007.

Kilian J, Stubbings J.

J Manag Care Pharm. 2007 Jan-Feb;13(1):59-65. Review.PMID: 17269838 [PubMed - indexed for MEDLINE]Related articlesFree article